Evidence map›Paper›PMID 25685062›Full record

ArticleCancer cell international2015

EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells.

Jing Cui, Wendong Sun, Xuexi Hao, Minli Wei, Xiaonan Su, Yajing Zhang, Ling Su, Xiangguo Liu

Abstract read
In one paragraph

Article in Cancer cell international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing Cui *Shandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.
Wendong Sun *The Second Hospital, Shandong University, Jinan, China.
Xuexi HaoThe Second Hospital, Shandong University, Jinan, China.
Minli WeiShandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.
Xiaonan SuShandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.
Yajing ZhangShandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.
Ling SuShandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.
Xiangguo LiuShandong University School of Life Sciences, Room 103, South Building, 27 Shanda South Road, Jinan, 250100 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BIX-01294, an euchromatic histone-lysine N-methyltransferase 2 (EHMT2) inhibitor, has been reported to induce apoptosis in human neuroblastoma cells and inhibit the proliferation of bladder cancer cells. However, the definite mechanism of the apoptosis mediated by BIX-01294 in bladder cancer cells remains unclear. In the present study, we found that BIX-01294 induced caspase-dependent apoptosis in human bladder cancer cells. Moreover, our data show BIX-01294 stimulates endoplasmic reticulum stress (ER stress) and up-regulated expression of PMAIP1 through DDIT3 up-regulation. Furthermore, down-regulation of the deubiquitinase USP9X by BIX-01294 results in downstream reduction of MCL1 expression, leading to apoptosis eventually. Thus, our findings demonstrate PMAIP1-USP9X-MCL1 axis may contribute to BIX-01294-induced apoptosis in human bladder cancer cells.

Indexed as

ApoptosisBIX-01294DDIT3EHMT2ER stressMCL1PMAIP1USP9X

Identifiers

PMID25685062
PMCPMC4326523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.